DE602004027362D1 - Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 - Google Patents

Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320

Info

Publication number
DE602004027362D1
DE602004027362D1 DE602004027362T DE602004027362T DE602004027362D1 DE 602004027362 D1 DE602004027362 D1 DE 602004027362D1 DE 602004027362 T DE602004027362 T DE 602004027362T DE 602004027362 T DE602004027362 T DE 602004027362T DE 602004027362 D1 DE602004027362 D1 DE 602004027362D1
Authority
DE
Germany
Prior art keywords
respiratory syncytial
syncytial virus
compositions
stamm
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004027362T
Other languages
English (en)
Inventor
Xing Cheng
Hyun Jung Park
Hong Jin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune LLC
Original Assignee
MedImmune LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedImmune LLC filed Critical MedImmune LLC
Publication of DE602004027362D1 publication Critical patent/DE602004027362D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE602004027362T 2003-03-28 2004-03-26 Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 Expired - Lifetime DE602004027362D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45833103P 2003-03-28 2003-03-28
US50832003P 2003-10-03 2003-10-03
PCT/US2004/009438 WO2004087062A2 (en) 2003-03-28 2004-03-26 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320

Publications (1)

Publication Number Publication Date
DE602004027362D1 true DE602004027362D1 (de) 2010-07-08

Family

ID=33135096

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004027362T Expired - Lifetime DE602004027362D1 (de) 2003-03-28 2004-03-26 Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320

Country Status (8)

Country Link
US (3) US7572904B2 (de)
EP (1) EP1613345B1 (de)
JP (1) JP4783726B2 (de)
AT (1) ATE469170T1 (de)
AU (1) AU2004226369A1 (de)
CA (1) CA2520671C (de)
DE (1) DE602004027362D1 (de)
WO (1) WO2004087062A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1572108A4 (de) * 2002-09-27 2008-09-17 Medimmune Vaccines Inc Funktionale mutationen des rsv (respiratory syncytial virus)
WO2004087062A2 (en) * 2003-03-28 2004-10-14 Medimmune Vaccines, Inc. Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
FR2885139B1 (fr) 2005-04-29 2010-12-24 Agronomique Inst Nat Rech Preparation de complexes solubles proteine n-proteine p tronquee ou de proteine n soluble d'un virus de la famille des paramyxoviridae et leurs utilisations vaccinales
US20070190560A1 (en) * 2006-02-13 2007-08-16 Olga Ornatsky Element-tagged olignucleotide gene expression analysis
EP2004686A1 (de) * 2006-03-06 2008-12-24 Symphogen A/S Rekombinanter polyklonaler antikörper zur behandlung von infektionen mit dem respiratory syncytial virus
FR2899902B1 (fr) * 2006-04-18 2012-01-27 Agronomique Inst Nat Rech Proteines de fusion proteine n d'un virus de la famille des paramyxoviridae-proteine d'interet et leurs utilisations pour la vaccination et la vectorisation intra-cellulaire.
CA2678628A1 (en) * 2007-03-06 2008-09-12 Symphogen A/S Recombinant antibodies for treatment of respiratory syncytial virus infections
US20090017517A1 (en) * 2007-07-13 2009-01-15 Medimmune, Llc Preparation of Negative-Stranded RNA Viruses by Electroporation
US8354230B2 (en) 2007-12-21 2013-01-15 Quest Diagnostics Investments Inc. Multiplex detection assay for influenza and RSV viruses
WO2010053883A1 (en) * 2008-11-05 2010-05-14 Merck Sharp & Dohme Corp. Live, attentuated respiratory syncytial virus
GB201019240D0 (en) 2010-11-15 2010-12-29 Vib Vzw Respiratory syncytical virus vaccine
US10227569B2 (en) 2011-04-12 2019-03-12 Emory University Respiratory syncytial virus expression vectors
CN105189756B (zh) 2013-03-14 2021-06-11 爱默蕾大学 具有沉默突变的重组rsv、其相关疫苗和方法
KR20180085730A (ko) 2015-10-29 2018-07-27 에모리 유니버시티 키메라 rsv, 면역원성 조성물, 및 사용 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800078A (en) * 1987-05-28 1989-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
US5840520A (en) * 1989-08-28 1998-11-24 Aviron Recombinant negative strand RNA virus expression systems
GB9200117D0 (en) * 1992-01-06 1992-02-26 Connaught Lab Production of recombinant chimeric proteins for vaccine use
IL105456A (en) * 1992-04-21 1996-12-05 American Home Prod Vaccines of attenuated respiratory syncytial virus
US20030054505A1 (en) * 1997-09-26 2003-03-20 Hong Jin Recombinant rsv expression systems and vaccines
US6713066B1 (en) * 1996-07-15 2004-03-30 The United States Of America As Represented By The Department Of Health And Human Services Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
EP0932684A2 (de) 1996-09-27 1999-08-04 American Cyanamid Company Mutationen in der genomischen 3'promoterregion und im polymerasegen, die für die attenuierung von viren der ordnung mononegavirales verantwortlich sind
US6017694A (en) 1997-12-19 2000-01-25 American Cyanamid Company Methods of screening for modulators of respiratory syncytial virus matrix protein interaction
EP1064358A2 (de) * 1998-03-26 2001-01-03 American Cyanamid Company Mutationen die für abschwächung von masern-virus oder von menschlichen respiratorischen synzytialvirus verantwortlich sind
EP1920783A1 (de) 2000-11-28 2008-05-14 MedImmune Vaccines, Inc. Rekombinante RSV-Virusexpressionssysteme und -impfstoffe
KR100964413B1 (ko) * 2001-01-19 2010-06-15 비로노바티브 비.브이. 감응성 포유류에서 호흡계 질환을 유발하는 바이러스
EP1572108A4 (de) * 2002-09-27 2008-09-17 Medimmune Vaccines Inc Funktionale mutationen des rsv (respiratory syncytial virus)
WO2004087062A2 (en) * 2003-03-28 2004-10-14 Medimmune Vaccines, Inc. Compositions and methods involving respiratory syncytial virus subgroup b strain 9320

Also Published As

Publication number Publication date
JP4783726B2 (ja) 2011-09-28
CA2520671C (en) 2014-03-18
CA2520671A1 (en) 2004-10-14
US20090285853A1 (en) 2009-11-19
US20040224309A1 (en) 2004-11-11
AU2004226369A1 (en) 2004-10-14
US7572904B2 (en) 2009-08-11
ATE469170T1 (de) 2010-06-15
EP1613345A2 (de) 2006-01-11
WO2004087062A2 (en) 2004-10-14
EP1613345A4 (de) 2007-01-10
US8163530B2 (en) 2012-04-24
US20120263744A1 (en) 2012-10-18
JP2006524053A (ja) 2006-10-26
WO2004087062A3 (en) 2005-03-31
EP1613345B1 (de) 2010-05-26

Similar Documents

Publication Publication Date Title
DE69922958D1 (de) Hcv hüllproteine partikel : verwendung für therapeutische impfung
NL300897I2 (nl) Neisseira meningitidis serogroep B recombinant gelipideerd fHbp subfamilie A05 eiwit
CA2253636A1 (en) Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
DE602004027362D1 (de) Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320
WO2003086451A8 (en) Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses
DE60125381D1 (de) Zusammensetzungen und verfahren mit analogen von g-csf
AU9078401A (en) Antimicrobial peptides and methods of use
WO2000075350A3 (en) Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
WO2002072036A3 (en) Compositions and methods comprising west nile virus polypeptides
AU6160201A (en) Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells
BRPI0411363A (pt) seqüências de ácidos nucléicos codificando e composições compreendendo peptìdeo sinal ige e/ou il-15 e processos para uso das mesmas
WO2004085633A8 (en) A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof
MXPA05005202A (es) Vacuna.
ATE543833T1 (de) Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen
WO2005035558A3 (en) Piscirickettsia salmonis antigens and use thereof
WO2000012535A3 (en) Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
WO2005011571A3 (en) Hepatitis virus core proteins as vaccine platforms and methods of use thereof
HUP0100267A2 (hu) Helicobacter pylori eredetű nukleinsav- és aminosav-szekvenciák és a megfelelő nukleinsavakat vagy peptideket tartalmazó vakcina-készítmények
WO1999058639A3 (en) Structural proteins of fish pancreatic disease virus and uses thereof
WO2001055353A3 (en) Recombinant attenuation of prrsv
WO2004020591A3 (en) Methods of use for novel human polypeptides encoded by polynucleotides
WO2004087886A3 (en) Modified adenoviral e1a constructs and methods of use thereof
WO2001049712A3 (en) Vaccine against isav (infectious salmon anaemia virus)
WO2003082206A3 (en) Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses
WO2004039952A8 (en) Methods of use for novel human polypeptides encoded by polynucleotides

Legal Events

Date Code Title Description
8364 No opposition during term of opposition